Search Results - N.   I. Sultanbaeva

Combination BRAF/MEK Inhibitor Targeted Therapy and Immunotherapy (atezolizumab + vemurafenib + cobimetinib) for Metastatic Cutaneous Melanoma: Clinical Case by V. E. Askarov, A. V. Sultanbaev, K. V. Menshikov, V. S. Chalov, N. I. Sultanbaeva, I. A. Menshikova

Get full text

Predictors of Multiple Primary Malignancies: Literature Review by A. V. Sultanbaev, K. V. Menshikov, Sh. I. Musin, A. A. Izmailov, I. A. Menshikova, N. I. Sultanbaeva

Get full text

Eribulin in Metastatic Breast Cancer: Actual Clinical Practice by A. V. Sultanbaev, K. V. Menshikov, Sh. I. Musin, I. A. Menshikova, N. I. Sultanbaeva, E. V. Popova, V. E. Askarov

Get full text

Level of tumor-infiltrating lymphocytes and PD status as potential prognostic markers of survival and therapy effectiveness in triple-negative breast cancer by A. F. Nasretdinov, N. I. Sultanbaeva, Sh. I. Musin, A. V. Pushkarev, K. V. Menshikov, V. A. Pushkarev, A. V. Sultanbaev

Get full text

Neuroendocrine Tumours: a Literature Review by K. V. Menshikov, A. V. Sultanbaev, Sh. I. Musin, I. A. Menshikova, A. F. Nasretdinov, N. I. Sultanbaeva, I. R. Shaykhutdinov

Get full text

Combined Use of Cabozantinib and Nivolumab in Clinical Practice by V. E. Askarov, A. V. Sultanbaev, K. V. Menshikov, Sh. I. Musin, N. I. Sultanbaeva, E. V. Popova, I. A. Menshikova

Get full text

Immune Checkpoint Inhibitors in Urothelial Carcinoma (Literature Review) by K. V. Menshikov, A. V. Sultanbaev, Sh. I. Musin, A. A. Izmailov, O. N. Lipatov, I. A. Menshikova, N. I. Sultanbaeva, E. V. Popova

Get full text

Prospects of PARP Inhibitors in Treatment of BRCA-Mutated Pancreatic Cancer: a Literature Review by K. V. Menshikov, A. V. Sultanbaev, Sh. I. Musin, A. A. Izmailov, I. A. Menshikova, N. I. Sultanbaeva, E. V. Popova, L. A. Khammatova

Get full text

Atezolizumab and Bevacizumab in Therapy for Patients with Hepatocellular Carcinoma in Real Clinical Practice by G. A. Serebrennikov, К. V. Menshikov, A. V. Sultanbaev, Sh. I. Musin, I. A. Menshikova, N. I. Sultanbaeva, D. O. Lipatov, A. Sh. Rezyapova

Get full text

Possible applications for combined lenvatinib and pembrolizumab in advanced endometrial carcinoma by K. V. Menshikov, A. V. Sultanbaev, Sh. I. Musin, I. A. Menshikova, N. I. Sultanbaeva, A. A. Izmailov, A. A. Fatikhova, D. O. Lipatov, G. A. Serebrennikov

Get full text

Hepatocellular Carcinoma: Aetiology and Mechanisms of Development. A Literature Review by K. V. Menshikov, A. V. Sultanbaev, Sh. I. Musin, I. R. Rakhmatullina, I. A. Menshikova, R. R. Abdeev, N. I. Sultanbaeva, E. V. Popova, G. A. Serebrennikov

Get full text

Efficiency of combined endocrine therapy with CDK4/6 inhibitors in metastatic HR⁺/HER2^- breast cancer: Immunological aspects by A. V. Sultanbaev, I. A. Tuzankina, I. V. Kolyadina, A. F. Nasretdinov, Sh. I. Musin, N. I. Sultanbaeva, K. V. Menshikov, A. A. Izmailov, M. V. Sultanbaev, D. A. Kudlay

Get full text

Breast cancer screening in germline mutation carriers. A literature review by A. V. Sultanbaev, A. F. Nasretdinov, M. G. Galeev, K. V. Menshikov, Sh. I. Musin, N. I. Sultanbaeva, R. T. Ayupov, R. R. Rakhimov, O. N. Lipatov, A. A. Izmaylov, I. A. Menshikova, G. A. Serebrennikov, D. O. Lipatov

Get full text

Multilineal treatment strategy of HER2-positive metastatic breast cancer (clinical case) by A.   F. Nasretdinov, A.   V. Pushkarev, O.  N.  Lipatov, N.   I. Sultanbaeva, Sh.   I. Musin, K.   V. Menshikov, A.   A. Izmailov, V.   A. Pushkarev, M.   G. Galeev, R.   R. Muginov, R.   B. Valiakhmedov, D.   D. Sakaeva, A.   V. Sultanbaev

Get full text